Itau Unibanco Holding S.A. Inovio Pharmaceuticals, Inc. Transaction History

Itau Unibanco Holding S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$1.41 - $2.5 $3,744 - $6,640	-2,656 Reduced 19.59%	10,899 $17,000
Q3 2022 Nov 14, 2022	SELL	$1.66 - $2.79 $11,623 - $19,535	-7,002 Reduced 34.06%	13,555 $23,000
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $18,732 - $51,775	13,009 Added 172.35%	20,557 $36,000
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $6,556 - $9,802	1,314 Added 21.08%	7,548 $39,000
Q3 2021 Nov 12, 2021	BUY	$7.16 - $9.69 $15,308 - $20,717	2,138 Added 52.2%	6,234 $45,000
Q2 2021 Aug 17, 2021	BUY	$6.23 - $10.03 $25,518 - $41,082	4,096 New	4,096 $38,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $489M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.